Abstract

IntroductionOutcomes following bacterial meningitis are significantly improved by adjunctive treatment with corticosteroids. However, little is known about the levels and significance of intrathecal endogenous cortisol. The aim of this study was to assess cortisol as a biological and diagnostic marker in patients with bacterial meningitis.MethodsForty-seven consecutive patients with bacterial meningitis and no prior treatment were evaluated. For comparison, a group of 37 patients with aseptic meningitis and a group of 13 healthy control individuals were included.ResultsThe mean age of the bacterial meningitis patients was 42 years, and the mean Glasgow Coma Scale, Acute Physiology and Chronic Health Evaluation II, and Sequential Organ Failure Assessment scores on admission were 12, 13 and 4, respectively. Altogether, 40 patients (85%) were admitted to the intensive care unit, with a median (interquartile range) length of stay of 8 (4 to 15) days. A bacterial etiology was confirmed in 35 patients (74%). The median (interquartile range) cortisol concentration in cerebrospinal fluid (CSF) was 133 (59 to 278) nmol/l. CSF cortisol concentrations were positively correlated with serum cortisol levels (r = 0.587, P < 0.001). Furthermore, CSF cortisol levels correlated with Acute Physiology and Chronic Health Evaluation II score (r = 0.763, P < 0.001), Sequential Organ Failure Assessment score (r = 0.650, P < 0.001), Glasgow Coma Scale score (r = -0.547, P < 0.001) and CSF lactate levels (r = 0.734, P < 0.001). CSF cortisol was only weakly associated with intrathecal levels of IL-6 (r = 0.331, P = 0.02) and IL-8 (r = 0.296, P < 0.05). CSF cortisol levels in bacterial and aseptic meningitis significantly differed (P < 0.001). The CSF cortisol concentration of 46.1 nmol/l was found to be the optimal cutoff value for diagnosis of bacterial meningitis.ConclusionCSF cortisol levels in patients with bacterial meningitis are highly elevated and correlate with disease severity. Moreover, our findings also suggest that intrathecal cortisol may serve as a valuable marker in discriminating between bacterial and aseptic meningitis.

Highlights

  • Outcomes following bacterial meningitis are significantly improved by adjunctive treatment with corticosteroids

  • cerebrospinal fluid (CSF) cortisol levels correlated with Acute Physiology and Chronic Health Evaluation II score (r = 0.763, P < 0.001), Sequential Organ Failure Assessment score (r = 0.650, P < 0.001), Glasgow Coma Scale score (r = -0.547, P < 0.001) and CSF lactate levels (r = 0.734, P < 0.001)

  • Four patients (8%) exhibited severe neurological sequelae by day 28, and surgery was necessary in six patients after they had completed the antibiotic regimen for bacterial meningitis

Read more

Summary

Introduction

Outcomes following bacterial meningitis are significantly improved by adjunctive treatment with corticosteroids. The aim of this study was to assess cortisol as a biological and diagnostic marker in patients with bacterial meningitis. APACHE = Acute Physiology and Chronic Health Evaluation; CSF = cerebrospinal fluid; GCS = Glasgow Coma Scale; GOS = Glasgow Outcome Score; IL = interleukin; ROC = receiver operating characteristic, SOFA = Sequential Organ Failure Assessment; TNF = tumour necrosis factor; WBC = white blood cell. Use of various biological markers in blood (C-reactive protein, white blood cell count [WBC], and procalcitonin) or cerebrospinal fluid (CSF; for instance, protein, glucose, WBC, lactate, inflammatory cytokines and combinations thereof) has been suggested to improve sensitivity in determining the aetiological diagnosis [48]. A sensitive laboratory test that is easy to perform is still required, so that all patients with bacterial meningitis can be identified reliably on admission

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.